Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical impact of SNP of P53 genes pathway on the adult AML patients.

Hematology (Amsterdam, Netherlands) - 1 Jul 2015

Abdel Hamid Thoraya M, El Gammal Mosaad M, Eibead Gamal T, Saber Mostafa M, Abol Elazm Omnia M

Abstract excerpt

INTRODUCTION: Acute myeloid leukemia (AML) is a highly heterogeneous disease, with biologically and prognostically different subtypes. AIM: To study the impact of p53, p21, and mdm2 gene polymorphisms on the clinical outcome in adult AML patients treated at the National Cancer Institute (NCI) - Cairo University. METHODS: Forty-eight adult AML patients presented to the Medical Oncology Department, NCI, from April...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Disease-Free Survival
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotyping Techniques

Share to Leukemia, Myeloid, Acute

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Share to Young Adult

Source

Identifiers

PMID: 25232917
DOI: 10.1179/1607845414Y.0000000200

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical impact of SNP of P53 genes pathway on the adult AML patients.PMID 25232917Read ↗

MDM2 SNP309 and p53 codon 72 genetic polymorphisms and risk of AML: an Egyptian study.Semantic proximity Read ↗

MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.Semantic proximity Read ↗

Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review.Semantic proximity Read ↗

[Clinical and prognostic values of TP53 mutation in patients with acute myeloid leukemia].Semantic proximity Read ↗

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutationsSemantic proximity Read ↗

Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysisSemantic proximity Read ↗

Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.Semantic proximity Read ↗

Establishment of tumor protein p53 mutation-based prognostic signatures for acute myeloid leukemia.Semantic proximity Read ↗

The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis.Semantic proximity Read ↗

MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.Semantic proximity Read ↗

The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases.Semantic proximity Read ↗

[Clinical characteristics and therapeutic effect of TP53 variant in patients with acute leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.